Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

KORU Medical Systems (KRMD) FCF Margin (2020 - 2025)

Historic FCF Margin for KORU Medical Systems (KRMD) over the last 11 years, with Q3 2025 value amounting to 0.12%.

  • KORU Medical Systems' FCF Margin rose 246700.0% to 0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45%, marking a year-over-year increase of 48700.0%. This contributed to the annual value of 4.81% for FY2024, which is 151000.0% up from last year.
  • Per KORU Medical Systems' latest filing, its FCF Margin stood at 0.12% for Q3 2025, which was up 246700.0% from 4.8% recorded in Q2 2025.
  • KORU Medical Systems' FCF Margin's 5-year high stood at 15.21% during Q4 2022, with a 5-year trough of 66.73% in Q1 2023.
  • For the 5-year period, KORU Medical Systems' FCF Margin averaged around 16.51%, with its median value being 7.07% (2025).
  • As far as peak fluctuations go, KORU Medical Systems' FCF Margin tumbled by -575600bps in 2022, and later skyrocketed by 608800bps in 2024.
  • KORU Medical Systems' FCF Margin (Quarter) stood at 11.73% in 2021, then soared by 230bps to 15.21% in 2022, then fell by -18bps to 12.53% in 2023, then decreased by -11bps to 11.12% in 2024, then plummeted by -99bps to 0.12% in 2025.
  • Its FCF Margin stands at 0.12% for Q3 2025, versus 4.8% for Q2 2025 and 7.07% for Q1 2025.